Search

everythinglearnresearchcommunity

for

Search:↓

Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Potential therapeutic targets for scarring hair loss are identified.

Sublingual minoxidil increases hair thickness in men with hair loss.

Deucravacitinib helped a man regrow hair significantly.

Changes in hair follicle structure may help diagnose and monitor alopecia.

Miliacin helps damaged hair follicles grow new hair faster.

Robotic hair transplants are easier and quicker to learn than traditional methods.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

A new wearable device stops hair loss and boosts hair growth safely.

Linalool in fragrances may harm hair follicles and contribute to hair loss.

Visualizing data helps guide future androgenetic alopecia research and policies.

Most patients know about minoxidil for hair loss, but concerns about its use and effectiveness affect their decision to use it.

Low zinc levels in hair and serum are linked to chronic hair loss.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

Dermatologists should know hair prosthetic options to better help alopecia patients.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

A new image-based method improves accuracy in measuring hair loss in mice.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

3D ultrasound can detect hair follicle changes and disease phases in alopecia areata.

A new image-based method improves accuracy in measuring hair loss in mice.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Severe allergic reactions to hair dye can trigger hair loss and may be linked to multiple sclerosis.